AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (April 16, 2008). doi:10.1152/ajprenal.00038.2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wang, Z.
Right arrow Articles by Wang, W.-H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.
Right arrow Articles by Wang, W.-H.
Submitted on January 23, 2008
Accepted on April 8, 2008

Arachidonic acid (AA) inhibits basolateral K channels in the cortical collecting duct (CCD) via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways

ZhiJian Wang1, Yuan Wei1, John R. Falck2, Krishnam Raju Atcha3, and Wen-Hui Wang4*

1 Pharmacology, New York Medical College, Valhalla, New York, United States
2 Biochemistry, UT Southwestern Medical Center at Dallas, Dallas, Texas, United States; , United States
3 Biochemistry, UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
4 Dept of Pharmacology, New York Medical College, Valhalla, New York, United States

* To whom correspondence should be addressed. E-mail: wenhui_wang{at}nymc.edu.

We used the patch-clamp technique to study the effect of arachidonic acid (AA) on basolateral 18 pS K channels in the principal cell of the cortical collecting duct (CCD) of the rat kidney. Application of AA inhibited the 18 pS K channels in a dose-dependent manner and 10 µM AA caused a maximal inhibition. The effect of AA on the 18 pS K channel was specific because application of 11,14,17-eicosatrienoic acid (EA) had no effect on channel activity. Also, the inhibitory effect of AA on the 18 pS K channels was abolished by blocking CYP epoxygenase with MS-PPOH but was not affected by inhibiting CYP {omega}-hydroxylase or cyclooxygenase. The notion that the inhibitory effect of AA was mediated by CYP epoxygenase-dependent metabolites was further supported by the observation that application of 100 nM 11,12-epoxyeicosatrienoic acid (EET) mimicked the effect of AA and inhibited the basolateral 18 pS K channels. In contrast, addition of either 5,6-, 8,9-, or 14,15-EET failed to inhibit the 18 pS K channels. Moreover, application of 11,12-EET was still able to inhibit the 18 pS K channels in the presence of MS-PPOH. This suggests that 11,12-EET is a mediator for the AA-induced inhibition of the 18 pS K channels. We conclude that AA inhibits basolateral 18 pS K channels by a CYP epoxygenase-dependent pathway and that 11,12-EET is a mediator for the effect of AA on basolateral K channels in the CCD.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.